PerkinElmer
check quantity

Solaris Fluorescence Image-Guided Surgery System

Solaris™ 开放式荧光手术导航成像系统是一种突破性研究工具,可实现临床前活体转化成像。作为一款多物种成像系统,可与多种荧光探针配合使用,为成像应用开发和外科研究提供多种用途。

部件号 CLS139884
立即购买

请输入有效的数量

请登录后再添加至收藏夹

购物车为空

项目已成功添加到购物车

For research use only. Not for use in diagnostic procedures.

详情 信息

Solaris 专为多物种的临床前研究、转化医学研究和新兴兽医外科研究应用而设计。

系统极为灵活,不仅满足侵入式、术中和浅表型非侵入式荧光成像的需要,同时也满足多种临床前研究成像应用需求,包括肿瘤、炎症、心血管疾病、牙医、疫苗研制和新药开发。

性能特点:

  • 针对大型和小型动物的开放式荧光成像,尤其适用于肿瘤切除导航成像
  • 在正常光照条件下操作,无需暗室
  • 多光谱覆盖(470 – 800 nm)
  • 四通道荧光成像支持多种荧光染料(470、660、750、800 nm)
  • 实时视频或静态影像
  • 手术级白光照明装置和荧光激发照明装置
  • 医用级显示器
  • 直观易用的操作界面

规格

显像模式 Optical Imaging
产品品牌名称 Solaris
资源,活动及更多信息
  • 所有

Video Article

产品手册

Solaris Open Air Fluorescence Imaging System (Product Note)

In vivo Imaging out in the open. Solaris™ open-air fluorescence imaging system is a,high impact research tool that enables translational,in vivo preclinical imaging. Solaris is a multispecies,imaging system designed for use with a broad,spectral range of fluorescent probes enabling versatility in imaging,application development and surgical research.

PDF 815 KB
小动物仪器及应用综合样本

小动物活体成像综合产品彩页

PDF 22 MB

海报

Open air fluorescence imaging of tumors using a new, multi-channel translational imaging system

palpate the tumor and tumor margins. Small tumor nodules can be missed or tumor margins may be inadequately removed, resulting in the need for secondary treatment. Intraoperative fluorescence imaging can help improve the initial resection and, therefore, both improve outcomes and reduce cost. Unconjugated fluorescent dyes have been previously used for this type of study to identify tumors in first-in-human studies. However, dyes conjugated to a targeting moiety have better specificity for the tumor itself and provide better guidance for the surgeon to locate the tumor and remove margins.,The new SolarisTM imaging system is an open air fluorescence imaging instrument designed specifically for intraoperative imaging in small to large animals. The system supports 4 different fluorescence channels to image common dyes (e.g. indocyanine green [ICG] and Fluorescein isothiocyanate [FITC]) and more unique near-infrared (NIR) fluorescent dyes. All of these can be imaged in ambient light to achieve sensitivities of 10 nM for single, long exposures and 10-100 nM for videos. The imaging head is attached to an adjustable arm so that it be can be positioned 75 cm above the object plane, far enough to be considered outside of the sterile field. The imaging head also has two cameras for simultaneous fluorescence and bright field (color) imaging; these images can be overlaid in the software. Single, long exposure images acquired from 2 different wavelengths can be overlaid to enable multiplexing and improve tumor identification; previously published studies have shown this to be useful for sentinel lymph node detection. For FITC, a custom liquid crystal tunable filter (LCTF) is included in the system in tandem with spectral unmixing software to separate tissue autofluorescence from fluorescence emitted by the dye.,Although this system is designed for larger animals, proof of concept intraoperative tumor resection has been performed in rodents. Subcutaneous tumors have been resected while imaging rats injected with the targeted agent IntegriSense™ 680. During the surgical procedures, both the residual tumor bed (in vivo) and the resected tumors (ex vivo) can be imaged to confirm complete resection in an ambient light environment. To investigate a more challenging model, tumor cell lines have also been implanted intraperitoneally in rats. After injection with either the targeted agent BombesinRSense™ 680 and the activatable agent ProSense® 750, deep tissue tumors were readily identified during a comprehensive necropsy. Although there are depth limitations due to the absorption and scattering of light in tissue, some tumors are still visible non-invasively. These results suggest that intraoperative resection of tumors detected with both targeted and activatable fluorescent agents is feasible using the new Solaris imaging system.

PDF 2 MB
Open air fluorescence imaging using the Solaris imaging system

Intraoperative tumor resection relies on the ability of the surgeon to discriminate tumor from healthy tissue, either visually or by palpation. Small tumor nodules can be missed or tumor margins may be inadequately removed, resulting in the need for secondary treatment. Intraoperative fluorescence imaging can help improve the initial resection, both improving outcomes and reducing cost. First-in-human studies have examined this theorem using unconjugated fluorescent dyes.[1] However, dyes conjugated to a targeting moiety have superior specificity for the tumor itself and provide enhanced guidance for the surgeon to locate the tumor and determine the margin of resection.[2],The new Solaris system was recently introduced specifically for intraoperative imaging in research environments.[3] The system supports 4 different fluorescence channels to image common dyes (e.g. indocyanine green [ICG] and Fluorescein isothiocyanate [FITC]) and more unique functionalized targeted or activated near-infrared (NIR) fluorescent agents in an ambient light environment. Recent data illustrate sensitivities of 10 nM for static snapshots and 10-100 nM for real-time acquisition at video frame rates, all under ambient lighting conditions. To achieve increased sensitivity focused fluorescence images are required, therefore an algorithmic autofocus approach has been implemented to find the ideal focal plane. Additionally, snapshots acquired at different wavelengths can be overlaid to enable multiplexing and improve tumor identification; previously published studies have shown this to be useful for sentinel lymph node mapping.[4] For FITC, where the emission spectra overlaps with tissue autofluorescence, spectral unmixing software has been used to process narrow band images acquired through a liquid crystal tunable filter (LCTF).,Although this system is designed for translational research in larger animals, proof of concept intraoperative tumor resection has been performed in rodents. Dosing and timing effects for epi-fluorescence images of subcutaneous and intraoperative surgical imaging has been investigated with both targeted and activatable agents. Subcutaneous tumors have been resected with the aid of intraoperative imaging in animals injected with IntegriSense 680. Tumor cell lines have also been implanted intrasplenically in rats; the subsequent deep tissue tumors were identified intraoperatively and removed after injection with either BombesinRSense 680 or ProSense 750. Lymphatic draining, a common problem in tumor metastasis, was also investigated in mice using AngioSense 680. These results suggest that intraoperative resection of tumors identified with both targeted and activatable fluorescent agents is feasible using the new Solaris imaging system.

PDF 1 MB
Translational System for Open-Air Fluorescence Imaging

In vivo studies have traditionally been limited to rodents due to the limitations of light penetration in tissue and have also utilized enclosed instruments to reduce background signals. There has been interest in extending fluorescent angiography into the clinic using naked fluorescent dyes (e.g. indocyanine green [ICG], FITC, methylene blue) although the depth limitations sometimes require X-ray angiography techniques. Clinical utilization of fluorescence guided surgery, on the other hand, has tremendous potential and can leverage targeted fluorescent probes that are much more specific. These probes are becoming increasingly relevant in translational studies as characterization advances and the mechanisms of action become better understood. In fact, some early first-in-human studies using naked fluorescent dyes and/or targeted agents for image guided surgery show potential. Utilization has not been widespread, due in part to the lack of instrumentation for preclinical imaging. Some recent handheld systems are available but preclude simultaneous imaging and resection of tumors. Surgical microscopes have longer working distances but are less natural to use. Other open-field commercial systems have working distances of less than 25 cm, limiting an operator’s visibility of the surgical field while imaging. We have previously reported on a system suitable for translational imaging that used pulsed illumination to interweave white and fluorescent lighting. White light pulsing reduces the illumination brightness and therefore makes utilization more challenging. In this paper we report on a system using filtered white light illumination to remove leakage into the fluorescence image and detect (and overlay) color and monochrome fluorescence images using the latest generation of sCMOS cameras. A distributed arrangement of low power LEDs can generate as much white illumination as a surgical lamp and also have good shadow control. Fluorescent excitation light in visible wavelengths can be pulsed at rates fast enough to appear continuous to the naked eye. To improve sensitivity in the band corresponding to FITC emission (500-600nm), long exposure snapshots can be used to acquire multispectral data using a customized liquid crystal tunable filter (LCTF) and unmix autofluorescence from the fluorophore signal. As a proof of concept, we use intrasplenic mouse models injected with targeted fluorescent agents and resect the tumors during the imaging procedure.

PDF 750 KB